Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioventus (BVS) Profit After Tax (2020 - 2026)

Bioventus filings provide 6 years of Profit After Tax readings, the most recent being $14.8 million for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 2546.93% to $14.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.6 million, a 163.84% increase, with the full-year FY2025 number at $22.7 million, up 148.32% from a year prior.
  • Profit After Tax hit $14.8 million in Q4 2025 for Bioventus, up from $4.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $24.9 million in Q2 2021 to a low of -$100.0 million in Q2 2023.
  • Median Profit After Tax over the past 5 years was -$5.4 million (2024), compared with a mean of -$17.0 million.
  • Biggest five-year swings in Profit After Tax: tumbled 3109.92% in 2022 and later surged 2546.93% in 2025.
  • Bioventus' Profit After Tax stood at -$26.0 million in 2021, then plummeted by 72.58% to -$44.9 million in 2022, then plummeted by 46.16% to -$65.6 million in 2023, then soared by 99.08% to -$603000.0 in 2024, then surged by 2546.93% to $14.8 million in 2025.
  • The last three reported values for Profit After Tax were $14.8 million (Q4 2025), $4.0 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.